症状性孕妇重症COVID-19及ICU入院的内部验证预测模型
该多中心回顾性队列纳入4国8家医院793例RT-PCR确诊SARS-CoV-2感染的症状性孕妇及产后早期(分娩后10天内)女性,开发mini-COvid-MIT与full-COvid-MIT两个模型预测重症COVID-19需ICU。迷你模型含年龄、BMI、孕晚期诊断,乐观校正AUC 0.73;完整模型含BMI、下呼吸道症状、NLR、CRP,AUC 0.85。任一模型判为高风险与更短诊断至ICU间隔、更高孕产妇死亡及子痫前期相关。
要点
- mini-COvid-MIT模型纳入年龄、BMI、孕晚期诊断,乐观校正AUC 0.73。
- full-COvid-MIT模型纳入BMI、下呼吸道症状、NLR、CRP,乐观校正AUC 0.85。
- 任一模型判为高风险者,诊断至ICU间隔更短(log-rank P<.001),孕产妇死亡(5.2% vs 0.2%;P<.001)及子痫前期(5.7% vs 1.0%;P<.001)更高。
核心结论
- 症状性COVID-19孕妇及近期产后女性就诊时即可被分层为重症高危与低危,即使在资源有限地区也可行,有助于支持照护性质与地点决策。
研究设计与样本
- 多中心回顾性队列研究,纳入4国(英国、奥地利、希腊、土耳其)8家医院,数据提取2020年2月至2021年5月,连续纳入RT-PCR确诊SARS-CoV-2感染的孕妇及产后早期(分娩后10天内)女性。
- 采用对数二项混合效应回归分析12个候选预测因子与主要结局(需ICU的重症进展)的关联,报告调整风险比(RR),并在两个模型中分别评估全部潜在预测因子与仅基线因素;以受试者工作特征曲线下面积(AUC)评估预测准确性。
主要发现
- 793例SARS-CoV-2阳性且症状性孕妇中,44例(5.5%)入住ICU,其中10例死亡(1.3%)。
- mini-COvid-MIT模型:母亲年龄调整RR 1.45(95%CI 1.07-1.95;P=.015),BMI调整RR 1.34(95%CI 1.06-1.66;P=.010),孕晚期诊断调整RR 3.64(95%CI 1.78-8.46;P=.001);乐观校正AUC 0.73。
- full-COvid-MIT模型:BMI调整RR 1.39(95%CI 1.07-1.95;P=.015),下呼吸道症状调整RR 5.11(95%CI 1.81-21.4;P=.007),中性粒细胞与淋巴细胞比值(NLR)调整RR 1.62(95%CI 1.36-1.89;P<.001),血清C反应蛋白(CRP)调整RR 1.30(95%CI 1.15-1.44;P<.001);乐观校正AUC 0.85。
- 两个模型均无拟合不良迹象;任一模型判为高风险与更短诊断至ICU入院间隔(log-rank P<.001,两者均)、更高孕产妇死亡(5.2% vs 0.2%;P<.001)及子痫前期(5.7% vs 1.0%;P<.001)相关。
关键数值与推荐
- mini-COvid-MIT模型包含发病时可获得的人口学与临床变量:母亲年龄、BMI、孕晚期诊断,乐观校正AUC 0.73。
- full-COvid-MIT模型包含BMI、下呼吸道症状、NLR、血清CRP,乐观校正AUC 0.85。
- 两个模型均提供电子表格计算器用于风险估计。
临床怎么用
- 对有症状的COVID-19孕妇及近期产后女性,就诊时可用模型分层为重症高危与低危,辅助决定照护性质与地点。
- 模型提示肥胖是重症独立风险,即使无其他合并症,也应强调该人群接种疫苗的重要性。
- 模型可为政策制定者优先安排国家疫苗接种规划、快速保护重症及死亡最高危人群提供信息。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnant women are at an increased risk of mortality and morbidity owing to COVID-19. Many studies have reported on the association of COVID-19 with pregnancy-specific adverse outcomes, but prediction models utilizing large cohorts of pregnant women are still lacking for estimating the risk of maternal morbidity and other adverse events. OBJECTIVE: The main aim of this study was to develop a prediction model to quantify the risk of progression to critical COVID-19 and intensive care unit admission in pregnant women with symptomatic infection. STUDY DESIGN: This was a multicenter retrospective cohort study including 8 hospitals from 4 countries (the United Kingdom, Austria, Greece, and Turkey). The data extraction was from February 2020 until May 2021. Included were consecutive pregnant and early postpartum women (within 10 days of birth); reverse transcriptase polymerase chain reaction confirmed SARS-CoV-2 infection. The primary outcome was progression to critical illness requiring intensive care. The secondary outcomes included maternal death, preeclampsia, and stillbirth. The association between the primary outcome and 12 candidate predictors having a known association with severe COVID-19 in pregnancy was analyzed with log-binomial mixed-effects regression and reported as adjusted risk ratios. All the potential predictors were evaluated in 1 model and only the baseline factors in another. The predictive accuracy was assessed by the area under the receiver operating characteristic curves. RESULTS: Of the 793 pregnant women who were positive for SARS-CoV-2 and were symptomatic, 44 (5.5%) were admitted to intensive care, of whom 10 died (1.3%). The 'mini-COvid Maternal Intensive Therapy' model included the following demographic and clinical variables available at disease onset: maternal age (adjusted risk ratio, 1.45; 95% confidence interval, 1.07-1.95; P=.015); body mass index (adjusted risk ratio, 1.34; 95% confidence interval, 1.06-1.66; P=.010); and diagnosis in the third trimester of pregnancy (adjusted risk ratio, 3.64; 95% confidence interval, 1.78-8.46; P=.001). The optimism-adjusted area under the receiver operating characteristic curve was 0.73. The 'full-COvid Maternal Intensive Therapy' model included body mass index (adjusted risk ratio, 1.39; 95% confidence interval, 1.07-1.95; P=.015), lower respiratory symptoms (adjusted risk ratio, 5.11; 95% confidence interval, 1.81-21.4; P=.007), neutrophil to lymphocyte ratio (adjusted risk ratio, 1.62; 95% confidence interval, 1.36-1.89; P<.001); and serum C-reactive protein (adjusted risk ratio, 1.30; 95% confidence interval, 1.15-1.44; P<.001), with an optimism-adjusted area under the receiver operating characteristic curve of 0.85. Neither model showed signs of a poor fit. Categorization as high-risk by either model was associated with a shorter diagnosis to intensive care unit admission interval (log-rank test P<.001, both), higher maternal death (5.2% vs 0.2%; P<.001), and preeclampsia (5.7% vs 1.0%; P<.001). A spreadsheet calculator is available for risk estimation. CONCLUSION: At presentation with symptomatic COVID-19, pregnant and recently postpartum women can be stratified into high- and low-risk for progression to critical disease, even where resources are limited. This can support the nature and place of care. These models also highlight the independent risk for severe disease associated with obesity and should further emphasize that even in the absence of other comorbidities, vaccination is particularly important for these women. Finally, the model also provides useful information for policy makers when prioritizing national vaccination programs to quickly protect those at the highest risk of critical and fatal COVID-19.
引用
- Kalafat E, Prasad S, Birol P, et al. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women. Am J Obstet Gynecol. 2021. PMID: 34582796. doi:10.1016/j.ajog.2021.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。